Egalet's Series C Round

Egalet raised a round of funding on September 14, 2013.

Egalet is a specialty pharmaceutical company developing and planning to commercialize abuse-deterrent oral products for the treatment of pain and other indications. The company has created two distinc…

Articles about Egalet's Series C Round: